Scholar Rock announces $75M common stock offering

Scholar Rock Holding Corporation announced that it has commenced an underwritten public offering for $75M of shares of its common stock. Scholar Rock intends to use the net proceeds from the offering to advance apitegromab, develop its clinical and preclinical pipeline, as well as for working capital and other general corporate purposes. J.P. Morgan Securities and Piper Sandler & Co. are acting as joint book-running managers for the offering. BMO Capital Markets Corp. and Wedbush Securities are acting as co-managers for the offering.